1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014

Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014" provides data on the Juvenile Myelomonocytic Leukemia (JMML) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Juvenile Myelomonocytic Leukemia (JMML). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Juvenile Myelomonocytic Leukemia (JMML). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Juvenile Myelomonocytic Leukemia (JMML) 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Juvenile Myelomonocytic Leukemia (JMML) 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Prominent Drugs 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Merck and Co., Inc. 25
Clinical Trial Overview of Merck and Co., Inc. 25
Clinical Trial Overview of Top Institutes / Government 26
Fred Hutchinson Cancer Research Center 26
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 26
National Cancer Institute 28
Clinical Trial Overview of National Cancer Institute 28
Children's Oncology Group 29
Clinical Trial Overview of Children's Oncology Group 29
Roswell Park Cancer Institute 30
Clinical Trial Overview of Roswell Park Cancer Institute 30
Thomas Jefferson University 31
Clinical Trial Overview of Thomas Jefferson University 31
University of California, San Francisco 32
Clinical Trial Overview of University of California, San Francisco 32
Columbia University 33
Clinical Trial Overview of Columbia University 33
Wake Forest University 34
Clinical Trial Overview of Wake Forest University 34
Masonic Cancer Center 35
Clinical Trial Overview of Masonic Cancer Center 35
Five Key Clinical Profiles 36
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Disclaimer 99
Source 100

List of Tables
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Region, 2014* 6
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 25
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 26
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 28
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 29
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014* 30
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014* 31
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 32
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014* 33
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 34
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2014* 35

List of Figures
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 12
Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 98

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.